• Saved

Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy - PubMed

Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34087798/

doi: 10.3171/2020.10.JNS201787. Online ahead of print. 1 Departments of1Neurosurgery and. 2 2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland. 3 3Radiation Oncology, Johns Hopkins University School of Medicine; and. doi: 10.3171/2020.10.JNS201787. Online ahead of print. 1 Departments of1Neurosurgery and. 2 2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.